We recently witnessed the peaceful—if controversial—transition of the United States presidency. As with any major change in federal government, the scientific community has concerns about new directions and priorities that may affect the way science is conducted, funded, and used in the United States and elsewhere. Of particular note with this new administration are concerns that President Trump may not fully value science-based evidence, and that information and policy decisions will be made without due consideration of scientific evidence.
Author: Barbara Schaal